Literature DB >> 7516418

Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells.

S E Jacobsen1, C Okkenhaug, O P Veiby, D Caput, P Ferrara, A Minty.   

Abstract

The recently cloned interleukin 13 (IL-13) shares most investigated biological activities on B lymphocytes and monocytes with IL-4. In this study we investigated for the first time the potential role of IL-13 in the regulation of the growth of hematopoietic progenitor cells. IL-13 enhanced stem cell factor (SCF)-induced proliferation of Lin-Sca-1+ bone marrow progenitor cells more potently than IL-4. The effect of IL-13 was purely synergistic, since IL-13 alone stimulated no colony formation. Single cell experiments suggested that the synergistic effect of IL-13 on Lin-Sca-1+ progenitors was directly mediated. In contrast, IL-13 had no synergistic activity on SCF-induced proliferation of the more mature Lin-Sca-1- progenitor cells. Thus, the cloning frequency in response to SCF + IL-13 was at least 20-fold higher in the Lin-Sca-1+ than the Lin-Sca-1- progenitor cell population. Furthermore, IL-13 but not IL-4 synergistically enhanced colony formation of Lin-Sca-1+ progenitors in response to granulocyte/macrophage colony-stimulating factor (GM-CSF) (threefold), whereas both IL-4 and IL-13 enhanced G-CSF-induced colony formation (threefold), and neither of the two significantly affected CSF-1 and IL-3-induced proliferation. Finally, whereas stimulation of Lin-Sca-1+ progenitors by SCF + G-CSF resulted in the formation of 90% granulocytes, the addition of IL-13 resulted in the production of macrophages exclusively. This novel effect on differentiation was directly mediated, shared with IL-4, and could not be observed on Lin-Sca-1- progenitor cells. Collectively, these findings indicate a novel role of IL-13 in early myelopoiesis, partially overlapping but also different from that of IL-4.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516418      PMCID: PMC2191564          DOI: 10.1084/jem.180.1.75

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  T-cell and mast cell lines respond to B-cell stimulatory factor 1.

Authors:  T R Mosmann; M W Bond; R L Coffman; J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1.

Authors:  E R Stanley; A Bartocci; D Patinkin; M Rosendaal; T R Bradley
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

3.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

4.  Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3.

Authors:  C A Smith; D M Rennick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

5.  Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

Authors:  K Ikebuchi; G G Wong; S C Clark; J N Ihle; Y Hirai; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

6.  Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells.

Authors:  D Rennick; G Yang; C Muller-Sieburg; C Smith; N Arai; Y Takabe; L Gemmell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

7.  Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells.

Authors:  C Peschel; W E Paul; J Ohara; I Green
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

8.  Novel role of interleukin 7 in myelopoiesis: stimulation of primitive murine hematopoietic progenitor cells.

Authors:  F W Jacobsen; O P Veiby; C Skjønsberg; S E Jacobsen
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

9.  Proliferation and differentiation of highly enriched mouse hematopoietic stem cells and progenitor cells in response to defined growth factors.

Authors:  C E Müller-Sieburg; K Townsend; I L Weissman; D Rennick
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

10.  An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors.

Authors:  G Aversa; J Punnonen; B G Cocks; R de Waal Malefyt; F Vega; S M Zurawski; G Zurawski; J E de Vries
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  11 in total

1.  Congenic mice confirm that collagen X is required for proper hematopoietic development.

Authors:  Elizabeth Sweeney; Douglas Roberts; Tina Corbo; Olena Jacenko
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

2.  IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells.

Authors:  Hatem A Elshabrawy; Michael V Volin; Abdul B Essani; Zhenlong Chen; Iain B McInnes; Katrien Van Raemdonck; Karol Palasiewicz; Shiva Arami; Mark Gonzalez; Hossam M Ashour; Seung-Jae Kim; Guofei Zhou; David A Fox; Shiva Shahrara
Journal:  Angiogenesis       Date:  2018-01-11       Impact factor: 9.596

3.  Inhibition of caspase-8 activity promotes protective Th1- and Th2-mediated immunity to Leishmania major infection.

Authors:  Wânia F Pereira-Manfro; Flávia L Ribeiro-Gomes; Alessandra Almeida Filardy; Natália S Vellozo; Landi V C Guillermo; Elisabeth M Silva; Richard M Siegel; George A Dosreis; Marcela F Lopes
Journal:  J Leukoc Biol       Date:  2013-09-26       Impact factor: 4.962

4.  Ex vivo expansion of primitive hematopoietic cells for cellular therapies: An overview.

Authors:  T A McAdams; C E Sandstrom; W M Miller; J G Bender; E T Papoutsakis
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

5.  Altered endochondral ossification in collagen X mouse models leads to impaired immune responses.

Authors:  E Sweeney; M Campbell; K Watkins; C A Hunter; O Jacenko
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

6.  Treatment of uveitis with recombinant human interleukin-13.

Authors:  F G Roberge; M D de Smet; J Benichou; M F Kriete; J Raber; J Hakimi
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

7.  Innate immunity to Leishmania infection: within phagocytes.

Authors:  Marcela Freitas Lopes; Ana Caroline Costa-da-Silva; George Alexandre DosReis
Journal:  Mediators Inflamm       Date:  2014-07-07       Impact factor: 4.711

8.  Interleukin-13 maintains the stemness of conjunctival epithelial cell cultures prepared from human limbal explants.

Authors:  Andrea Stadnikova; Peter Trosan; Pavlina Skalicka; Tor Paaske Utheim; Katerina Jirsova
Journal:  PLoS One       Date:  2019-02-11       Impact factor: 3.240

9.  Interleukin-13 increases the stemness of limbal epithelial stem cells cultures.

Authors:  Peter Trosan; Joao Victor Cabral; Ingrida Smeringaiova; Pavel Studeny; Katerina Jirsova
Journal:  PLoS One       Date:  2022-08-02       Impact factor: 3.752

10.  Activated mast cells produce interleukin 13.

Authors:  P R Burd; W C Thompson; E E Max; F C Mills
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.